Avista Capital Partners has announced it has acquired Terrats Medical from Miura Partners.
Terrats, based in Barcelona, Spain, is a provider of dental prosthetics. The company sells into more than 50 countries.
Avista, based in New York, makes control buyout investments in middle market healthcare companies. Founded in 2005, the firm focuses on
Argosy Healthcare Partners (AHP) has announced the recapitalization of Command Medical Products.
Command, based in Ormond Beach, Fla., and founded in 1987, provides contract manufacturing services for medical devices sold by original equipment manufacturers and other device providers.
AHP, based in Wayne, Pa., is a lower middle market private equity investor focused exclusively
Thomas H. Lee Partners (THL) will take portfolio company Agiliti private, according to a news release.
THL is currently Agiliti’s majority shareholder. The firm will acquire all outstanding shares of Agiliti common stock for $10 per share in cash, implying an enterprise value of approximately $2.5 billion.
Agiliti, founded in 1939 and based
People have invested a lot in dermatology, dental and other areas and are now looking for the next sector. In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell is joined by Mitch Stern, managing director and head of healthcare at Dresner Partners, to discuss plastic surgery and medical spa investing.
The discussion
McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their
Harvest Partners has announced it has closed its latest fund with $5.34 billion of commitments.
The new fund, Harvest Partners IX, surpassed its target of $5.25 billion.
Harvest, based in New York, is a PE firm investing in middle-market companies generating between $100 million and $3 billion in revenue. Founded in 1981, the firm targets investments
The regulatory landscape for telehealth prescribing of controlled substances is evolving.
In episode 13 of Complications: Health Policy Unraveled, host Stephanie Kennan covers the DEA’s recent extension of pandemic-era telehealth prescribing flexibilities for controlled substances through 2024, marking the second extension. Originally set to expire in May, these extensions followed extensive public input, including 38,000
At McGuireWoods’ 16th annual Healthcare Finance & Growth (HCFG) Conference, a panel of dental industry leaders shared insights with attendees about the market. Panelists included Smiles Ahead COO Sean Barnard, SGA Dental Partners Vice President of M&A Jonathan Mikailonis, Polaris Healthcare Partners Co-founder and Partner Diwakar Sinha, and Edgemont Partners Managing Director Brett Skolnik. The
Hildred Capital Management will acquire Hello Bello, according to a news release.
Hello Bello, founded in 2019 and based in Pacific Palisades, Calif., produces baby and family care products.
Hildred, based in New York, is healthcare-focused private equity firm. Founded in 2018, the firm pursues growth equity investments and seeks to invest
OrbiMed has announced it has raised more than $4.3 billion in commitments for its latest private investment funds.
These new funds include OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.
OrbiMed, headquartered in New York, is a life sciences investment firm with more than $17 billion in